A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Abroad (travel likely)RecruitingPHASE3

Conditions

Cerebral Adrenoleukodystrophy (cALD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford University Medical Center, Palo Alto, California, United States
Contact: Study coordinator (Jacinda Sampson) · jacindas@stanford.edu · 650-723-0993
Neuro Medicine Hospital / UF Health, Gainesville, Florida, United States
Kennedy Krieger Institute, Baltimore, Maryland, United States
Contact: Study coordinator (Eric Mallack) · Mallack@kennedykrieger.org · 443-923-2750
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Reza Seyedsadjadi) · rseyedsadjadi@mgh.harvard.edu · 617-726-5175
University of Minnesota, Minneota, Minnesota, United States
Contact: Study coordinator (Troy Lund) · lundx072@umn.edu · 612-625-4185
Health University of Utah, Salt Lake City, Utah, United States
Hospital Austral, Buenos Aires, Argentina
Contact: Study coordinator (Hernan Amartino) · carolina.acevedo@resolutioncrs.com · +542304387458
Federal University of Sao Paulo, São Paulo, Brazil
Contact: Study coordinator (Paulo Sgobbi) · pvsgobbi@gmail.com · +55(11)913323742
ICM La Pitie Salpetriere, Paris, France
Contact: Study coordinator (Fanny Mochel) · fanny.mochel@icm-institute.org · + 33 (0)1 57 27 41 23
Klinik und Poliklinik für Neurologie-Leipzig, Leipzig, Germany
Contact: Study coordinator (Caroline Bergner) · Caroline.Bergner@medizin.uni-leipzig.de · +49 341 97 11747
Sir Ganga Ram Hospital, New Delhi, India
Contact: Study coordinator (C.S Agrawal) · csyvaa@gmail.com · +91 11 4225 1099
Hospital 12 de Octubre, Madrid, Spain
Contact: Study coordinator (Montserrat Morales) · montserrat.morales@salud.madrid.org · 630 742 050
National Hospital for Neurology and Neurosurgery, London, United Kingdom
Contact: Study coordinator (Robin Lachman) · r.lachmann@nhs.net · +442034484778

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Cerebral Adrenoleukodystrophy (CALD)

Abroad (travel likely)Recruiting

Boston, United States · Philadelphia, United States